Cancer
Conditions
Interventions
Case series:None
Sponsors
Nanfang Hospital of Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria for the lung cancer group. 1. Agde at least 18 years; 2. Voluntary signing of the informed consent; 3. Patients diagnosed with lung cancer by the standardized diagnosis of the Chinese Medical Association Clinical Guidelines for the Treatment of Lung Cancer (2022 edition); 4. No other malignant tumors other than lung cancer were confirmed. Inclusion criteria for the gastric cancer group. 1. Agde at least 18 years; 2. Voluntary signing of the informed consent; 3. Patients diagnosed as gastric cancer by the standardized diagnosis of the Chinese Medical Association Clinical Guidelines for the Treatment of Gastric Cancer (2022 edition); 4. No other malignant tumors other than gastric cancer were confirmed. Inclusion criteria for ovarian cancer group. 1. Agde at least 18 years; 2. Voluntary signing of the informed consent; 3. Patients diagnosed as ovarian cancer by the standardized diagnosis of the Chinese Medical Association Clinical Guidelines for the Treatment of Ovarian Cancer (2022 edition); 4. No other malignant tumors other than ovarian cancer were confirmed. Inclusion criteria for healthy individuals group. 1. Agde at least 18 years; 2. Voluntary signing of the informed consent; 3. No significant abnormal physical examination results; 4. No confirmed diagnosis of malignant tumor in the 6 months before enrollment.
Exclusion criteria
Exclusion criteria: Exclusion criteria for the lung cancer group: 1. Inability to collect blood, urine samples, stool samples, cancer and paracancerous tissue; 2. Missing diagnostic or treatment data; 3. Patients who had blood transfusion in the three months prior to enrollment; 4. Pregnant and lactating women. Exclusion criteria for the gastric cancer group: 1. Inability to collect blood, urine samples, stool samples, cancer and paracancerous tissue; 2. Missing diagnostic or treatment data; 3. Patients who had blood transfusion in the three months prior to enrollment; 4. Pregnant and lactating women. Exclusion criteria for the ovarian cancer group: 1. Inability to collect blood, urine samples, stool samples, cancer and paracancerous tissue; 2. Missing diagnostic or treatment data; 3. Patients who had blood transfusion in the three months prior to enrollment; 4. Pregnant and lactating women. Exclusion criteria for the healthy human group: Blood, urine samples, stool samples could not be collected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| proteomics;Genomics;metabolomics; | — |
Countries
China
Contacts
Public ContactLei Zheng
Nanfang Hospital of Southern Medical University
Outcome results
None listed